December 18, 2024 – Terumo Well being Outcomes (THO), a division of Terumo Interventional Methods (TIS), and Medis Medical Imaging, a number one cardiac imaging software program firm, introduced that they’ve entered right into a strategic partnership within the U.S. to advance cardiovascular care by means of using each ePRISM – Terumo's proprietary scientific determination help platform – and Medis' Quantitative Move Ratio (QFR) know-how, a non-invasive software program resolution designed to measure angiography-derived coronary physiology. The usage of ePRISM and Medis QFR shall be examined at choose scientific websites, utilizing real-time information from digital well being information to offer potential insights to assist enhance affected person care.

THO's collaboration with Netherlands-based Medis Medical Imaging represents an vital step in bettering scientific determination help capabilities, streamlining workflows and, most significantly, bettering affected person outcomes by offering interventional cardiologists with correct anatomical and physiological evaluations of coronary artery illness (CAD).

Proceed studying